Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-06-01

Clinical Trial Update: Efficacy, Safety and Dose Finding Trial of Topical Jaungo Application in Atopic Dermatitis Patients [Phase 2]

View source ↗

Summary

Phase 2 trial update reporting efficacy, safety, and dose-finding outcomes for topical Jaungo in atopic dermatitis; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Jaungo

Snippet

Sponsor: Kyung Hee University Hospital at Gangdong | Conditions: Dermatitis, Atopic | Phase 2 | Status: COMPLETED